S&P 500   3,963.51
DOW   33,781.48
QQQ   283.85
101 Christmas Gift Ideas Under $40
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
This Is Why Daktronics Fell 40% In One Day 
On the money: Yellen's next milestone is name on US currency
Surprise Yourself, Predict the Trends with A.I. (Ad)pixel
Biden releasing nearly $36B to aid pensions of union workers
Is It Time To Throw In The Towel On Gamestop?
Surprise Yourself, Predict the Trends with A.I. (Ad)pixel
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Thursday 12/8/2022
S&P 500   3,963.51
DOW   33,781.48
QQQ   283.85
101 Christmas Gift Ideas Under $40
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
This Is Why Daktronics Fell 40% In One Day 
On the money: Yellen's next milestone is name on US currency
Surprise Yourself, Predict the Trends with A.I. (Ad)pixel
Biden releasing nearly $36B to aid pensions of union workers
Is It Time To Throw In The Towel On Gamestop?
Surprise Yourself, Predict the Trends with A.I. (Ad)pixel
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Thursday 12/8/2022
S&P 500   3,963.51
DOW   33,781.48
QQQ   283.85
101 Christmas Gift Ideas Under $40
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
This Is Why Daktronics Fell 40% In One Day 
On the money: Yellen's next milestone is name on US currency
Surprise Yourself, Predict the Trends with A.I. (Ad)pixel
Biden releasing nearly $36B to aid pensions of union workers
Is It Time To Throw In The Towel On Gamestop?
Surprise Yourself, Predict the Trends with A.I. (Ad)pixel
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Thursday 12/8/2022
S&P 500   3,963.51
DOW   33,781.48
QQQ   283.85
101 Christmas Gift Ideas Under $40
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
This Is Why Daktronics Fell 40% In One Day 
On the money: Yellen's next milestone is name on US currency
Surprise Yourself, Predict the Trends with A.I. (Ad)pixel
Biden releasing nearly $36B to aid pensions of union workers
Is It Time To Throw In The Towel On Gamestop?
Surprise Yourself, Predict the Trends with A.I. (Ad)pixel
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Thursday 12/8/2022
NYSE:USNA

USANA Health Sciences - USNA Stock Forecast, Price & News

$51.88
-1.25 (-2.35%)
(As of 12/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$51.65
$53.51
50-Day Range
$48.66
$59.68
52-Week Range
$48.61
$103.26
Volume
50,916 shs
Average Volume
55,569 shs
Market Capitalization
$996.61 million
P/E Ratio
13.10
Dividend Yield
N/A
Price Target
$51.00

USANA Health Sciences MarketRank™ Forecast

Analyst Rating
Hold
1.50 Rating Score
Upside/​Downside
1.7% Downside
$51.00 Price Target
Short Interest
Healthy
3.53% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.05
Upright™ Environmental Score
News Sentiment
0.62mentions of USANA Health Sciences in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$100,531 Sold Last Quarter
Proj. Earnings Growth
2.13%
From $3.28 to $3.35 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.86 out of 5 stars

Medical Sector

804th out of 1,022 stocks

Medicinals & Botanicals Industry

11th out of 14 stocks

USNA stock logo

About USANA Health Sciences (NYSE:USNA) Stock

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Receive USNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

USNA Stock News Headlines

USANA Acquires Two Companies—Rise Bar & Oola
USANA Named Top Manufacturer in Utah
USANA Health Sciences Bottom Line Retreats In Q3, misses estimates
Earnings Preview: Usana Health Sciences
Usana Health Sciences (USNA) Trading Report
USANA Health Sciences is Now Oversold (USNA)
USNA USANA Health Sciences, Inc.
USANA Health Sciences, Inc. (USNA)
See More Headlines
Receive USNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

USNA Company Calendar

Last Earnings
10/25/2022
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/14/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
Personal Products
Sector
Medical
CUSIP
90328M10
Employees
1,978
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$51.00
High Stock Price Forecast
$53.00
Low Stock Price Forecast
$49.00
Forecasted Upside/Downside
-1.7%
Consensus Rating
Hold
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

Net Income
$116.50 million
Pretax Margin
11.32%

Debt

Sales & Book Value

Annual Sales
$1.19 billion
Cash Flow
$6.95 per share
Book Value
$20.30 per share

Miscellaneous

Free Float
19,137,000
Market Cap
$996.61 million
Optionable
Optionable
Beta
0.71

Key Executives

  • Mr. Kevin G. Guest (Age 59)
    Chairman & CEO
    Comp: $1.52M
  • Mr. Jim  BrownMr. Jim Brown (Age 53)
    Pres
    Comp: $1M
  • Mr. G. Douglas Hekking (Age 52)
    Chief Financial Officer
    Comp: $764.98k
  • Mr. Walter  NootMr. Walter Noot (Age 56)
    Chief Operating Officer
    Comp: $739.06k
  • Mr. David Mulham (Age 62)
    Chief Sales Officer
    Comp: $828.52k
  • Dr. Myron W. WentzDr. Myron W. Wentz (Age 81)
    Founder & Chairman Emeritus
  • Dr. John Cuomo
    Exec. Director of Product Devel. & Technology
  • Dr. Robert A. SinnottDr. Robert A. Sinnott (Age 57)
    Chief Scientific Officer
  • Mr. Patrique Richards
    Exec. Director of Investor Relations & Bus. Devel.
  • Mr. P. Joshua FoukasMr. P. Joshua Foukas (Age 46)
    Chief Legal Officer, Gen. Counsel & Corp. Sec.













USNA Stock - Frequently Asked Questions

Should I buy or sell USANA Health Sciences stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" USNA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in USNA, but not buy additional shares or sell existing shares.
View USNA analyst ratings
or view top-rated stocks.

What is USANA Health Sciences' stock price forecast for 2023?

2 equities research analysts have issued 1 year price targets for USANA Health Sciences' stock. Their USNA share price forecasts range from $49.00 to $53.00. On average, they expect the company's stock price to reach $51.00 in the next year. This suggests that the stock has a possible downside of 1.7%.
View analysts price targets for USNA
or view top-rated stocks among Wall Street analysts.

How have USNA shares performed in 2022?

USANA Health Sciences' stock was trading at $101.20 at the beginning of the year. Since then, USNA shares have decreased by 48.7% and is now trading at $51.88.
View the best growth stocks for 2022 here
.

When is USANA Health Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 14th 2023.
View our USNA earnings forecast
.

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) announced its quarterly earnings results on Tuesday, October, 25th. The company reported $0.78 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.89 by $0.11. The company had revenue of $233.30 million for the quarter, compared to analyst estimates of $247.70 million. USANA Health Sciences had a net margin of 7.41% and a trailing twelve-month return on equity of 19.22%.

How will USANA Health Sciences' stock buyback program work?

USANA Health Sciences announced that its Board of Directors has approved a share buyback plan on Tuesday, February 9th 2021, which permits the company to repurchase $150,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 8.2% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board believes its stock is undervalued.

What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences issued an update on its FY 2022 earnings guidance on Tuesday, November, 1st. The company provided EPS guidance of $3.15-$3.40 for the period, compared to the consensus EPS estimate of $3.90. The company issued revenue guidance of $955.00 million-$975.00 million, compared to the consensus revenue estimate of $1.03 billion.

What is Kevin Guest's approval rating as USANA Health Sciences' CEO?

68 employees have rated USANA Health Sciences Chief Executive Officer Kevin Guest on Glassdoor.com. Kevin Guest has an approval rating of 99% among the company's employees. This puts Kevin Guest in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of USANA Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include International Business Machines (IBM), Gilead Sciences (GILD), NVIDIA (NVDA), AT&T (T), BioMarin Pharmaceutical (BMRN), Vertex Pharmaceuticals (VRTX), AbbVie (ABBV), Walt Disney (DIS), Intuitive Surgical (ISRG) and Johnson & Johnson (JNJ).

What is USANA Health Sciences' stock symbol?

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

Who are USANA Health Sciences' major shareholders?

USANA Health Sciences' stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.57%), Vanguard Group Inc. (7.71%), Renaissance Technologies LLC (6.81%), Pzena Investment Management LLC (3.76%), Dimensional Fund Advisors LP (2.93%) and State Street Corp (2.04%). Insiders that own company stock include Brent Neidig, Daniel A Macuga, Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Gilbert A Fuller, Jim Brown, John Turman Fleming, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott, Robert Auciaux, Timothy E Wood and Walter Noot.
View institutional ownership trends
.

How do I buy shares of USANA Health Sciences?

Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is USANA Health Sciences' stock price today?

One share of USNA stock can currently be purchased for approximately $51.88.

How much money does USANA Health Sciences make?

USANA Health Sciences (NYSE:USNA) has a market capitalization of $996.41 million and generates $1.19 billion in revenue each year. The company earns $116.50 million in net income (profit) each year or $3.96 on an earnings per share basis.

How many employees does USANA Health Sciences have?

The company employs 1,978 workers across the globe.

How can I contact USANA Health Sciences?

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The official website for the company is www.usana.com. The company can be reached via phone at (801) 954-7100, via email at investor.relations@usanainc.com, or via fax at 801-954-7300.

This page (NYSE:USNA) was last updated on 12/9/2022 by MarketBeat.com Staff